✦ LIBER ✦

Bevacizumab shows promise for high-risk and recurrent ovarian cancer

✍ Scribed by SUSAN LONDON

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab and erlotinib show promise f

✍ Heather Lindsey 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 116 KB

Gene therapy shows promise for breast an

✍ Lisa Barrie Schwartz 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 130 KB

Sequential bevacizumab and oral cyclopho

✍ Ursula A. Matulonis; Lauren Pereira; Joyce Liu; Hang Lee; Julie Lee; Christin Wh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Combination gemcitabine, platinum, and b

✍ Debra L. Richardson; Floor J. Backes; Leigh G. Seamon; Vanna Zanagnolo; David M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Recurrence patterns after extended treat

✍ Dao, Minh D.; Alwan, Laura M.; Gray, Heidi J.; Tamimi, Hisham K.; Goff, Barbara 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Effects of bevacizumab and pegylated lip

✍ Kazuya Kudoh; Masashi Takano; Hiroko Kouta; Ryoko Kikuchi; Tsunekazu Kita; Morik 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 402 KB